Oral liposomal delivery system
AssigneeBioZone Laboratories, Inc.
InventorBrian C. Keller
Life of this patent
Estimating the term…
Loading patent…
AssigneeBioZone Laboratories, Inc.
InventorBrian C. Keller
Estimating the term…
A liposome-capsule dosage unit system for the delivery of a biologically active material is formed by encapsulating a biologically active materials in liposomes and then placing the liposome encapsulated material into a capsule. The capsule is typically a soft gel capsule or a two piece capsule capable of tolerating a certain amount of water. A less water tolerant capsule can be employed if the liposomes are dehydrated prior to placement within the capsule. Biologically active material include drugs, nutritional supplements, vitamins, minerals, enzymes, hormones, proteins and polypeptides. The system is especially suited for the delivery of materials with poor oral solubility, materials that are not absorbed or are poorly absorbed from the gastrointestinal tract, and materials that have conventionally been given by an invasive route. The system can be administered orally, intra-occularly, intranasally, rectally, or vaginally.
A method for preparing a liposome formulation in a gelatin capsule, comprising:
A capsule for delivering an active ingredient to a subject comprising a liposome dispersion, wherein said liposome dispersion comprises a lipid component, an active ingredient component, a water component, and an oil component such that said dispersion comprises liposomes in a fluid medium, wherein said fluid medium comprises said water and said oil components.
A method for administering a biologically active material to a subject, which method comprises introducing a capsule to the subject by oral administration, wherein:
Dependencies are inferred from the claim text.